Recherche
Résultats 71-72 de 72
-
Efficacy of alemtuzumab over 6?years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: post hoc analysis of the care-ms studies
Multiple sclerosis (Houndmills, Basingstoke, England), 01-11-2019, 1352458519881759Article dans une revue scientifique -
Expert opinion on the use of cladribine tablets in clinical practice
Therapeutic advances in neurological disorders, 01-01-2020, 13, 1756286420935019Article dans une revue scientifique